Atlas Trials

Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients

Clinical trial NCT05306249 · COMPLETED

Trial details

NCT number
NCT05306249
Sponsor
Centre Hospitalier Régional d'Orléans
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Seropositivity
Start date
2022-05-16
Primary completion
2023-02-08
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.